Trial intelligence / Profile preview

Acute Unilateral Vestibulopathy and Corticosteroid Treatment

NCT02912182Phase 4Terminated

Sponsor
Lund University
Start
Dec 2015
Primary completion
Mar 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial of betamethasone and prednisolone in vestibular neuronitis (3 arms), sponsored by Lund University. Primary endpoint: Caloric function at 1 year. Started Dec 2015; status: terminated.

02

Drugs

betamethasoneprednisolone
03

Conditions

vestibular neuronitis

Beyond the preview

Go deeper on NCT02912182.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02912182.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call